Elevated Aβ aggregates in feces from Alzheimer's disease patients: a proof-of-concept study

被引：1

作者：

Pils, Marlene ^{[1
,2
]}

Dybala, Alexandra ^{[3
]}

Schaffrath, Anja ^{[1
]}

Rehn, Fabian ^{[1
,2
]}

Kutzsche, Janine ^{[1
]}

Bloemeke, Lara ^{[1
]}

Tusche, Markus ^{[1
]}

Oezduezenciler, Pelin ^{[1
]}

Bujnicki, Tuyen ^{[1
]}

Kraemer-Schulien, Victoria ^{[1
]}

Gramespacher, Hannes ^{[4
]}

Schmieschek, Maximilian H. T. ^{[4
]}

Barbe, Michael T. ^{[4
]}

Onur, Oezguer A. ^{[4
,5
]}

Fink, Gereon R. ^{[4
,5
]}

Tamguney, Gultekin ^{[1
,3
]}

Bannach, Oliver ^{[1
,2
]}

Willbold, Dieter ^{[1
,2
,3
]}

机构：

[1] Forschungszentrum Julich, Inst Biol Informat Proc, Struct Biochem IBI 7, D-52428 Julich, Germany

[2] attyloid GmbH, D-40225 Dusseldorf, Germany

[3] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany

[4] Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Neurol, D-50937 Cologne, Germany

[5] Res Ctr Julich, Inst Neurosci & Med INM 3, Cognit Neurosci, D-52428 Julich, Germany

来源：

ALZHEIMERS RESEARCH & THERAPY | 2024年 / 16卷 / 01期

关键词：

Amyloidosis; A beta oligomer quantitation; sFIDA; Brain-gut-microbiota axis; Leaky gut; Fecal/stool samples; Clearance; MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID; GUT-MICROBIOTA; DIAGNOSIS; BRAIN;

D O I：

10.1186/s13195-024-01597-3

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

BackgroundMisfolding and aggregation of amyloid beta (A beta), along with neurofibrillary tangles consisting of aggregated Tau species, are pathological hallmarks of Alzheimer's disease (AD) onset and progression. In this study, we hypothesized the clearance of A beta aggregates from the brain and body into the gut.MethodsTo investigate this, we used surface-based fluorescence intensity distribution analysis (sFIDA) to determine the A beta aggregate concentrations in feces from 26 AD patients and 31 healthy controls (HC).ResultsA beta aggregates were detectable in human feces and their concentrations were elevated in AD patients compared to HC (specificity 90.3%, sensitivity 53.8%).ConclusionThus, fecal A beta aggregates constitute a non-invasive biomarker candidate for diagnosing AD. Whether digestion-resistant A beta aggregates in feces are secreted via the liver and bile or directly from the enteric neuronal system remains to be elucidated.

引用

页数：15

共 50 条

[11] Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study
McDade, Eric
Cummings, Jeffrey L.
Dhadda, Shobha
Swanson, Chad J.
Reyderman, Larisa
Kanekiyo, Michio
Koyama, Akihiko
Irizarry, Michael
Kramer, Lynn D.
Bateman, Randall J.
ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
[12] TMS-EEG Biomarkers of Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease: A Proof-of-Concept Six Years Prospective Study
Ferreri, Florinda
Guerra, Andrea
Vollero, Luca
Ponzo, David
Maeaetta, Sara
Koenoenen, Mervi
Vecchio, Fabrizio
Pasqualetti, Patrizio
Miraglia, Francesca
Simonelli, Ilaria
Corbetta, Maurizio
Rossini, Paolo Maria
FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
[13] An Ecologically Valid, Longitudinal, and Unbiased Assessment of Treatment Efficacy in Alzheimer Disease (the EVALUATE-AD Trial): Proof-of-Concept Study
Thomas, Neil William Douglas
Beattie, Zachary
Marcoe, Jennifer
Wright, Kirsten
Sharma, Nicole
Mattek, Nora
Dodge, Hiroko
Wild, Katherine
Kaye, Jeffrey
JMIR RESEARCH PROTOCOLS, 2020, 9 (05):
[14] Preclinical Alzheimer's Disease: Implications for Refinement of the Concept
Vos, Stephanie J. B.
Visser, Pieter Jelle
JOURNAL OF ALZHEIMERS DISEASE, 2018, 64 : S213 - S227
[15] Infrared Thermal Imaging Analysis in Screening for Toddler's Fracture: A Proof-of-Concept Study
Saatchi, Reza
Ramlakhan, Shammi
APPLIED SCIENCES-BASEL, 2023, 13 (24):
[16] Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients
Zenzmaier, Christoph
Marksteiner, Josef
Kiefer, Andreas
Berger, Peter
Humpel, Christian
JOURNAL OF NEUROCHEMISTRY, 2009, 110 (02) : 653 - 661
[17] Chylothorax as a Risk Factor for Thrombosis in Adults: A Proof-of-Concept Study
Hoskote, Sumedh S.
Yadav, Hemang
Jagtap, Prashant
Wigle, Dennis A.
Daniels, Craig E.
ANNALS OF THORACIC SURGERY, 2018, 105 (04): : 1065 - 1070
[18] Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease
Kosicek, M.
Zetterberg, H.
Andreasen, N.
Peter-Katalinic, J.
Hecimovic, S.
NEUROSCIENCE LETTERS, 2012, 516 (02) : 302 - 305
[19] Clinical Metagenomics-from Proof-of-Concept to Routine Use
Schlaberg, Robert
CLINICAL CHEMISTRY, 2022, 68 (08) : 997 - 999
[20] Elevated CNS inflammation in patients with preclinical Alzheimer's disease
Monson, Nancy L.
Ireland, Sara J.
Ligocki, Ann J.
Chen, Ding
Rounds, William H.
Li, Min
Huebinger, Ryan M.
Cullum, C. Munro
Greenberg, Benjamin M.
Stowe, Ann M.
Zhang, Rong
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2014, 34 (01): : 30 - 33

← 1 2 3 4 5 →